Three economists explore the viability of a UN-backed one-stop licensing ‘hub’ for making essential, often life-saving biotherapeutics and vaccines both affordable and more widely available.
Articles on Human papillomavirus
Displaying all articles
From skin warts to cancer why human papillomavirus deserves more attention and better awareness.
The immortal cancer cells of Henrietta Lacks revolutionized the fields of science, medicine and bioethics. And they still survive today, more than 70 years after her death.
Some cancers are actually caused by viruses that linger for long periods in the body, or cause physical damage that later turns cancerous.
Oral sex is common among young people. Protection from STIs is not.
Addressing these gaps in the vaccination programme will ensure more people are being protected against the type of cancer.
Researchers have found a way to encourage cervical cancer screenings and vaccinations in Korean American women. Might their findings also work in other underrepresented populations?
When British parents are informed of the risks of HPV, they want their sons to be vaccinated against the virus.
Medical research suggests cervical cancer screening for women under the age of 25 has little impact. Women should therefore be screened at a later age, and less often.
Prevention against cervical cancer is the main aim of the Gardasil vaccine. But HPV is also linked to a large proportion of anal, vaginal and head and neck cancers.
A new version of the HPV vaccine Gardasil protects against nine types of the virus, and is already being used overseas.
The kinds of vaccines adults need depend on several factors, including whether you were born here, how old you are and whether you intend to travel overseas.
Rwanda’s vaccination programme for girls against HPV, the most common sexually transmitted disease was a huge success, thanks to implementation science.
There is a lot of misinformation about the government’s new cervical cancer screening program that involves less frequent tests. Here are the facts.
Danish analysis of women receiving the human papillomavirus (HPV) vaccination has found no link between the vaccine and an…
The antiviral HIV drug lopinavir has been successfully used to treat women with human papillomavirus positive, early stage…
The human papillomavirus (HPV) vaccine has attracted attention in the past week for two contradictory reasons: the Japanese government has withdrawn its recommendation for the shot, while public health…
UK health authorities have recommended women start having pap smears later in life, suggesting women wait until they are at least 25 before having their first cervical cancer screening. The aim is to reduce…
A large US study has added further support to the safety of the Australian-developed human papillomavirus vaccine (HPV4). The study, published in Archives of Pediatrics & Adolescent Medicine, included…
Top contributors
-
Lecturer in the School of Women's and Children's Health, UNSW
-
Vice Chancellor, University of Global Health Equity
-
Professor of Family Medicine, University of Calgary
-
Associate Professor, City University of New York
-
Academic, Obstetrics and Gynaecology Royal Women's Hospital/Mercy, The University of Melbourne
-
Professor, Melbourne University, The Royal Women's Hospital
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW
-
Chair, Medical Advisory Committee, Australian Cancer Research Foundation; Director, Diamantina Institute for Cancer Immunology and Metabolic Medicine, The University of Queensland
-
Senior Lecturer, UNSW
-
Professor of Psychology, University of Sheffield
-
Professor of Children's Health, UCL
-
Associate Professor of Microbiology, Immunology and Cell Biology, West Virginia University
-
Assistant professor (College of Nursing @ University of Cincinnati), University of Cincinnati
-
Professor of Clinical Epidemiology and Health Data Science, Queen Mary University of London
-
PhD Candidate in Health Services Organization & Policy, University of Michigan